Improvement of Mycobacterium abscessus Pulmonary Disease after Nivolumab Administration in a Patient with Advanced Non-small Cell Lung Cancer

Nivolumab has become the standard second-line chemotherapy for non-small cell lung cancer. A 73-year-old man with stage IV non-small cell lung cancer received 6 cycles of chemotherapy with nab-paclitaxel/carboplatin/bevacizumab followed by 11 cycles of nab-paclitaxel/bevacizumab; however, treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Intern Med
Hauptverfasser: Ishii, Seigo, Tamiya, Akihiro, Taniguchi, Yoshihiko, Tanaka, Tsunehiro, Abe, Yuko, Isa, Shun-ichi, Tsuyuguchi, Kazunari, Suzuki, Katsuhiro, Atagi, Shinji
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Japanese Society of Internal Medicine 2018
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355398/
https://ncbi.nlm.nih.gov/pubmed/30101929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1195-18
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge